Pilot Program Expands Access to Science-Backed CBD for Senior Cancer Patients through Healthcare Insurance Coverage LOUISVILLE, Colo., Dec. 18, 2025 /PRNewswire/ - (TSX: CWEB) (OTCQB: CWBHF) Charlotte's Web Holdings, Inc., the  pioneer and trusted market leader in hemp-derived CBD wellness, is proud to participate as a CBD provider supporting the treatment of senior oncology patients under the newly announced landmark pilot program by the Center for Medicare and Medicaid Innovation (CMMI). For the first ti ...

Core Insights - Charlotte's Web has launched a new hemp-derived THC product called Knockout, expanding its Brightside collection into the sleep market, combining cannabinoids and fast-acting delivery technology to support quality sleep [2][3] Product Details - Knockout is a blackberry-flavored gummy infused with a balanced ratio of hemp-derived THC and CBN, designed to help users fall asleep and promote restful sleep throughout the night [2][3] - The proprietary AZUCA TiME INFUSION™ delivery system allows for rapid onset of effects, typically within 5 to 15 minutes [2][7] - Knockout retails for $39.99 for a 20-count package and is available online and at select retailers starting October 14, 2025 [4] Market Positioning - The sleep segment is one of the fastest-growing areas in wellness, and Charlotte's Web aims to lead the hemp wellness category with Knockout [3] - The product is positioned as a natural alternative to alcohol and traditional sleep aids, appealing to consumers seeking safe and reliable sleep solutions [3] Brand Commitment - Charlotte's Web emphasizes its commitment to ingredient integrity and science-backed formulations, enhancing its portfolio with innovative, fast-acting products [3][5] - The Brightside line includes other formulations such as Unwind, Focus, and Recover, showcasing the company's dedication to precision wellness [5]

Core Insights - Charlotte's Web Holdings, Inc. reported its second consecutive quarter of year-over-year revenue growth, achieving $12.8 million in Q2 2025, a 4.2% increase from $12.3 million in Q2 2024, driven by new product innovations and omnichannel expansion [1][12][10]. Financial Performance - The company achieved a gross profit of $6.0 million in Q2 2025, representing 46.8% of revenue, compared to $2.6 million or 21.0% of revenue in Q2 2024 [13][10]. - Selling, general, and administrative (SG&A) expenses decreased by 31.7% year-over-year to $10.1 million, down from $14.7 million in Q2 2024, reflecting effective cost management strategies [14][3]. - The net loss for Q2 2025 was $6.3 million, or $(0.04) per share, an improvement from a net loss of $11.1 million, or $(0.07) per share, in Q2 2024 [15][10]. Operational Developments - The company successfully transitioned to in-house production of its Brightside™ THC gummies, which has led to improved margins and accelerated product timelines [5][2]. - Charlotte's Web expanded its product portfolio with the introduction of CBG Focus & Attention Gummies and functional mushroom gummies, targeting high-growth segments in the wellness market [6][7]. Strategic Initiatives - The company is focused on enhancing its omnichannel presence, with digital sales contributions from platforms like TikTok Shop, Amazon, and Walmart.com [4][10]. - Charlotte's Web is actively pursuing regulatory advancements for hemp-derived products, anticipating a favorable regulatory environment that could benefit established brands [8][10]. Clinical and Research Progress - The collaboration with DeFloria, Inc. has commenced FDA-cleared Phase 2 clinical trials for a botanical drug candidate aimed at treating irritability associated with autism spectrum disorder, representing a potential long-term revenue opportunity [9][10].

Core Insights - Charlotte's Web Holdings, Inc. is set to report its second quarter results for 2025 on August 13, 2025, prior to market opening [1] - A conference call to discuss the results will take place on the same day at 11:00 A.M. Eastern Time [1] Company Overview - Charlotte's Web is a botanical wellness innovation company and a market leader in cannabidiol (CBD) hemp extract wellness products [3] - The company offers a range of products including whole-plant full-spectrum CBD extracts, broad-spectrum CBD, and cannabinoid isolates [3] - Product categories include CBD oil tinctures, CBD gummies for various purposes, CBN gummies, hemp-derived THC microdose gummies, functional mushroom gummies, CBD capsules, topical creams, lotions, and CBD products for pets [3] - The company employs a vertically integrated business model to ensure product quality and consistency, with rigorous testing from soil to shelf [3] - Products are distributed to retailers and healthcare practitioners across the U.S. and are available for online purchase [3]